연구성과로 돌아가기

2020 연구자 정보 (43 / 997)

※ 컨트롤 + 클릭으로 열별 다중 정렬 가능합니다.
Excel 다운로드
Author Name 제1저자 여부 교신저자 여부 Address ResearcherID ORCID Paper Title WoS Edition 최상위 JCR(%) WoS Category Related Email
Park, Y. S.
(Park, YS)
Samsung Med Ctr, Dept Internal Med, Div Hematol Oncol, Seoul, South Korea

[JCR상위 2.7] Prospective, open-label, observational study of cetuximab for metastatic colorectal carcinoma (mCRC): The OPTIM1SE study SCIE 2.7 ONCOLOGY
Pichler, Martin
(Pichler, M)
제1저자 Univ Texas MD Anderson Canc Ctr, Dept Expt Therapeut, Houston, TX 77030 USA
Med Univ Graz, Div Oncol, Graz, Austria

0000-0002-8701-9462
Pichler, Martin
[JCR상위 2.7] Therapeutic potential of FLANC, a novel primate-specific long non-coding RNA in colorectal cancer SCIE 2.7 GASTROENTEROLOGY & HEPATOLOGY glopez@mdanderson.org;gcalin@mdanderson.org;
Pokhrel, Nitin Kumar
(Pokhrel, NK)
Kyungpook Natl Univ, Sch Dent, Dept Biochem, Daegu, South Korea
Kyungpook Natl Univ, Sch Dent, Dept Biochem, IHBR, 2177 Dalgubeol Daero, Daegu 41940, South Korea


[JCR상위 2.7] 6-Shogaol, an active ingredient of ginger, inhibits osteoclastogenesis and alveolar bone resorption in ligature-induced periodontitis in mice
[JCR상위 22.5] Developmental Roles of FUSE Binding Protein 1 (Fubp1) in Tooth Morphogenesis
SCIE 2.7 DENTISTRY, ORAL SURGERY & MEDICINE
BIOCHEMISTRY & MOLECULAR BIOLOGY;CHEMISTRY, MULTIDISCIPLINARY
ylec@knu.ac.kr;ylee@knu.ac.kr;
yparyal86@gmail.com;sanjiv.knu@gmail.com;tae09290@daum.net;euiseon3488@gmail.com;nitinpokhrel.np@gmail.com;yhs2669@naver.com;hoho6434@gachon.ac.kr;chan@knu.ac.kr;syan@knu.ac.kr;epark@knu.ac.kr;endoking@knu.ac.kr;widenmy@knu.ac.kr;hyamamoto@tdc.ac.jp;chosome1@yuhs.ac;slee@knu.ac.kr;dykim82@knu.ac.kr;tykwon@knu.ac.kr;ylee@knu.ac.kr;wjsohn@dhu.ac.kr;jykim91@knu.ac.kr;
Rigoutsos, Isidore
(Rigoutsos, I)
Thomas Jefferson Univ, Computat Med Ctr, Philadelphia, PA 19107 USA
Thomas Jefferson Univ, Dept Pathol Anat & Cell Biol, Philadelphia, PA 19107 USA
C-5381-2012
Rigoutsos, Isidore
0000-0003-1529-8631
Rigoutsos, Isidore
[JCR상위 2.7] Therapeutic potential of FLANC, a novel primate-specific long non-coding RNA in colorectal cancer SCIE 2.7 GASTROENTEROLOGY & HEPATOLOGY glopez@mdanderson.org;gcalin@mdanderson.org;
Rodriguez-Aguayo, Cristian
(Rodriguez-Aguayo, C)
Univ Texas MD Anderson Canc Ctr, Dept Expt Therapeut, Houston, TX 77030 USA
Univ Texas MD Anderson Canc Ctr, Ctr RNA Interference & Noncoding RNA, Houston, TX 77030 USA

0000-0002-7880-7723
RODRIGUEZ-AGUAYO, CRISTIAN
[JCR상위 2.7] Therapeutic potential of FLANC, a novel primate-specific long non-coding RNA in colorectal cancer SCIE 2.7 GASTROENTEROLOGY & HEPATOLOGY glopez@mdanderson.org;gcalin@mdanderson.org;
Sawyer, W.
(Sawyer, W)
AstraZeneca, Biometr Oncol, Cambridge, England

[JCR상위 2.7] South Korean real-world treatment patterns in patients with EGFRm NSCLC SCIE 2.7 ONCOLOGY
Seo, S.
(Seo, S)
Asan Med Ctr, Dept Oncol, Seoul, South Korea
Chonbuk Natl Univ, Jeonju, South Korea


[JCR상위 2.7] Phase I dose-expansion (part II) study of ISU104 (a novel anti-ErbB3 monoclonal antibody) alone and combination with cetuximab (CET), in patients (pts) with recurrent/metastatic (R/M) head and neck squamous cell carcinoma (HNSCC)
[JCR상위 19.5] Current trend in the Helicobacter pylori eradication rates of first-line sequential and concomitant therapies in Korea: A nationwide multicenter retrospective study over the 10 years
SCIE 2.7 ONCOLOGY
GASTROENTEROLOGY & HEPATOLOGY;MICROBIOLOGY
Shin, S.
(Shin, S)
Kosin Univ Gospel Hosp, Dept Oncol Internal Med, Busan, South Korea

[JCR상위 2.7] Phase I dose-expansion (part II) study of ISU104 (a novel anti-ErbB3 monoclonal antibody) alone and combination with cetuximab (CET), in patients (pts) with recurrent/metastatic (R/M) head and neck squamous cell carcinoma (HNSCC) SCIE 2.7 ONCOLOGY
Slaby, Ondrej
(Slaby, O)
Masaryk Univ, Cent European Inst Technol, Brno, Czech Republic
Masaryk Mem Canc Inst, Dept Comprehens Canc Care, Brno, Czech Republic
E-1082-2012
Slaby, Ondrej

[JCR상위 2.7] Therapeutic potential of FLANC, a novel primate-specific long non-coding RNA in colorectal cancer SCIE 2.7 GASTROENTEROLOGY & HEPATOLOGY glopez@mdanderson.org;gcalin@mdanderson.org;
Taguchi, Ayumu
(Taguchi, A)
Univ Texas MD Anderson Canc Ctr, Dept Clin Canc Prevent, Houston, TX 77030 USA N-7396-2019
Taguchi, Ayumu

[JCR상위 2.7] Therapeutic potential of FLANC, a novel primate-specific long non-coding RNA in colorectal cancer SCIE 2.7 GASTROENTEROLOGY & HEPATOLOGY glopez@mdanderson.org;gcalin@mdanderson.org;
Taylor, A.
(Taylor, A)
AstraZeneca, Oncol Business Unit, Cambridge, England

[JCR상위 2.7] South Korean real-world treatment patterns in patients with EGFRm NSCLC SCIE 2.7 ONCOLOGY
Temraz, S.
(Temraz, S)
Amer Univ Beirut, Med Ctr, Dept Internal Med, Beirut, Lebanon

[JCR상위 2.7] Prospective, open-label, observational study of cetuximab for metastatic colorectal carcinoma (mCRC): The OPTIM1SE study SCIE 2.7 ONCOLOGY
Tran, Anh M.
(Tran, AM)
Univ Texas MD Anderson Canc Ctr, Dept Expt Therapeut, Houston, TX 77030 USA

[JCR상위 2.7] Therapeutic potential of FLANC, a novel primate-specific long non-coding RNA in colorectal cancer SCIE 2.7 GASTROENTEROLOGY & HEPATOLOGY glopez@mdanderson.org;gcalin@mdanderson.org;
Vychytilova-Faltejskova, Petra
(Vychytilova-Faltejskova, P)
Masaryk Univ, Cent European Inst Technol, Brno, Czech Republic
Masaryk Mem Canc Inst, Dept Comprehens Canc Care, Brno, Czech Republic
E-2805-2012
Vychytilova, Petra
0000-0003-0063-2078
Vychytilova, Petra
[JCR상위 2.7] Therapeutic potential of FLANC, a novel primate-specific long non-coding RNA in colorectal cancer SCIE 2.7 GASTROENTEROLOGY & HEPATOLOGY glopez@mdanderson.org;gcalin@mdanderson.org;
Wang, Zhihui
(Wang, ZH)
Houston Methodist Res Inst, Math Med Program, Houston, TX USA

[JCR상위 2.7] Therapeutic potential of FLANC, a novel primate-specific long non-coding RNA in colorectal cancer SCIE 2.7 GASTROENTEROLOGY & HEPATOLOGY glopez@mdanderson.org;gcalin@mdanderson.org;
페이지 이동: